Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
Sharon L AchillesClifton W KellyCraig J HoesleyDiana L BlitheJill E BrownBarbra A RichardsonBrid DevlinCraig W HendrixSamuel M PoloyacMark A MarzinkeHolly GundackerDevika SinghJeanna M PiperSherri JohnsonJohn SteytlerBeatrice A Chennull nullPublished in: PloS one (2024)
The extended duration DPV/ LNG rings were well tolerated and the observed DPV concentrations in plasma and cervicovaginal fluid when used continuously exceeded concentrations observed in previous DPV ring efficacy studies. LNG concentrations in plasma were comparable with other efficacious LNG-based contraceptives. Genital DPV concentrations had a short half-life and were thus not well sustained following ring removal.
Keyphrases